DS
APLS

DRW Securities’s Apellis Pharmaceuticals APLS Stock Holding History

DRW Securities’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,573
Closed -$1.35M – 965
2026
Q1 		$1.35M Buy
+33,573
New +$723K 0.02% 267

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DRW Securities's APLS Position: Q2 2026 in Review

DRW Securities sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 33,573 shares — an estimated $1.35M sold.

DRW Securities first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $1.35M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • DRW Securities reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 33,573 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.35M.
  • DRW Securities first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • DRW Securities's Apellis Pharmaceuticals position peaked at $1.35M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.